Wellgistics Health (NASDAQ:WGRX – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.07) EPS for the quarter, FiscalAI reports. The firm had revenue of $1.56 million for the quarter. Wellgistics Health had a negative return on equity of 1,617.25% and a negative net margin of 545.69%.
Wellgistics Health Trading Down 23.2%
Shares of WGRX opened at $0.13 on Thursday. Wellgistics Health has a 52-week low of $0.07 and a 52-week high of $2.66. The company has a quick ratio of 0.04, a current ratio of 0.09 and a debt-to-equity ratio of 1.86. The firm’s fifty day moving average is $0.12 and its two-hundred day moving average is $0.33. The stock has a market cap of $16.34 million, a PE ratio of -0.14 and a beta of -1.17.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Wellgistics Health in a research note on Friday, March 27th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.
Institutional Investors Weigh In On Wellgistics Health
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Geode Capital Management LLC boosted its stake in Wellgistics Health by 81.0% during the 4th quarter. Geode Capital Management LLC now owns 487,383 shares of the company’s stock worth $195,000 after purchasing an additional 218,170 shares during the last quarter. Raymond James Financial Inc. boosted its stake in Wellgistics Health by 593.8% during the 3rd quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock worth $52,000 after purchasing an additional 50,000 shares during the last quarter. XTX Topco Ltd boosted its stake in Wellgistics Health by 195.1% during the 4th quarter. XTX Topco Ltd now owns 106,087 shares of the company’s stock worth $42,000 after purchasing an additional 70,137 shares during the last quarter. Finally, Heights Capital Management Inc. acquired a new stake in Wellgistics Health during the 3rd quarter worth $2,588,000.
Wellgistics Health Company Profile
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
Featured Articles
- Five stocks we like better than Wellgistics Health
- The Palantir Paradox—Record Numbers and a Stock That Won’t Cooperate
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
Receive News & Ratings for Wellgistics Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health and related companies with MarketBeat.com's FREE daily email newsletter.
